The cost of insulin remains a barrier for many Americans with diabetes who depend on the drug, a study released Monday showed.
Study in Annals of internal medicine found that in 2021, nearly 1 in 5 US adults with diabetes either skipped, delayed, or used less insulin than needed to save money. This represents about 1.3 million adults, or 16.5% of those requiring insulin.
The findings are based on data from National Health Interview Survey 2021conducted annually by the Centers for Disease Control and Prevention and interviewing tens of thousands of Americans about their health experiences.
It was the first time the CDC included questions about insulin use, although concerns about high insulin prices have been reported for years.
For people who need insulin and have insurance, the bill that just passed the House will be a big help, capping the $35 a month amount for a life-sustaining prescription. But the bill doesn’t help the uninsured, says Kaiser Health News reporter Bram Sable-Smith. He explains the laws and talks about his diagnosis of type 1 diabetes.
From January 1, the Law on Reducing Inflation, which was signed by President Joe Biden in August, will cap the monthly cost of insulin at $35 for seniors on Medicare. The law, however, will leave out millions of Americans with private health insurance, as well as those who are uninsured.
Read the full story at NBCNews.com.